Atlas Trials

Metformin as a Neuroprotective Therapy for Glaucoma

Clinical trial NCT05426044 · RECRUITING

Trial details

NCT number
NCT05426044
Sponsor
Christopher Kai Shun Leung
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Glaucoma
Start date
2025-06-01
Primary completion
2027-12-31
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.